Leukocyte-endothelial cell interactions: potential targets for mesalazine in Crohn's disease.
Wakefield
A J
AJ
University Department of Medicine, Royal Free Hospital School of Medicine, London, England.
Hudson
M
M
Pounder
R E
RE
D000636:Aminosalicylic Acids / Q000494:pharmacology*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology*; D000938:Antigen-Presenting Cells / Q000502:physiology; D002448:Cell Adhesion; D002450:Cell Communication / Q000187:drug effects; D002465:Cell Movement; D002634:Chemotaxis, Leukocyte; D003424:Crohn Disease / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D004730:Endothelium, Vascular / Q000187:drug effects / Q000276:immunology / Q000503:physiopathology; D006801:Humans; D007962:Leukocytes / Q000187:drug effects / Q000502:physiology; D019804:Mesalamine
D000636:Aminosalicylic Acids; D000894:Anti-Inflammatory Agents, Non-Steroidal; D019804:Mesalamine